Multiple Sclerosis is a disease that causes the chronic degeneration of the central nervous system, affecting the brain and spinal cord. This cases the progressive loss of motor control, vision balance, sensation, as well as inflammation and muscular weakness.
This research outlines how doctors were surprised to see the symptoms of one of their MS patents improve after smoking cannabis on his on initiative. When submitted to a clinical study, it was found that the cannabinoids appeared to improve the patient’s symptoms of spasticity and Ataxia. Published in the Journal of Neurology.
2) Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study (2004)
This research aimed to find how patients suffering from spacidity caused by MS reacted to treatment with cannabis. It was found that the use of cannabis appeared to be safe and with tolerable side effects, whilst decreasing the amount of spasms encountered. Published in the Multiple Sclerosis Journal.
This study set out to assess the effects of cannabis based medicine on central pain caused by MS – a symptom that is largely unresponsive to other forms of treatment. It was concluded that cannabis based medicines were effective at reducing the perceived amount of pain, and that it also helped reduce the amount of sleep disturbances patients had. Published in the journal Neurology.
Research published in the Multiple Sclerosis Journal set out to validate the anecdotal reports that marijuana can help alleviate the symptoms of urinary tract problems caused by MS. It was found that the use of marijuana caused the number of incontinent episodes to decrease as well as decrease the amount voided. It was also reported that patients experienced less pain, spasticity and improved sleep.